Sign In
Buy CNMD
$35.16
+0.0300 (+0.0854%)
At Close: Jun 05, 2026
Do Hedge Funds Love Coca-Cola FEMSA, S.A.B. de C.V. (KOF)?
09:18pm, Tuesday, 07'th Apr 2020
Will the new coronavirus cause a recession in US in the next 6 months? On February 27th, we put the probability at 75% and we predicted that the market will decline by at least 20% in (Recession is Im
CONMED Corporation to Announce First Quarter 2020 Financial Results on April 29, 2020
08:05pm, Tuesday, 07'th Apr 2020
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter of 2020 after the market close on Wednesday, April 29, 2020. The Company’s management will
$0.57 Earnings Per Share Expected for CONMED Co. (NASDAQ:CNMD) This Quarter
09:48am, Monday, 06'th Apr 2020
Equities research analysts expect CONMED Co. (NASDAQ:CNMD) to post earnings per share (EPS) of $0.57 for the current quarter, according to Zacks Investment Research. Two analysts have made estimates f
High Cancer Morality to Drive Aspiration and Biopsy Needles Market Revenue beyond $1,717.9 Million by 2030: P&S Intelligence
09:00am, Monday, 06'th Apr 2020
Aspiration and Biopsy Needles Market Research Report: By Type (Core Needle, Fine Needle), Procedure (Image-Guided, Non-Image-Guided), Application (Breast Biopsy, Lung Biopsy,.
AQR Capital Management LLC Has $1.62 Million Holdings in CONMED Co. (NASDAQ:CNMD)
08:36am, Monday, 06'th Apr 2020
AQR Capital Management LLC cut its stake in CONMED Co. (NASDAQ:CNMD) by 20.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The
CONMED Co. (NASDAQ:CNMD) Expected to Announce Quarterly Sales of $211.14 Million
07:50am, Sunday, 05'th Apr 2020
Wall Street brokerages forecast that CONMED Co. (NASDAQ:CNMD) will post $211.14 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates
The "Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type, by Application, Outlook 2022" report has been added to
Brinker Capital Inc. Purchases 267 Shares of CONMED Co. (NASDAQ:CNMD)
09:04am, Friday, 03'rd Apr 2020
Brinker Capital Inc. increased its position in shares of CONMED Co. (NASDAQ:CNMD) by 6.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. Th
Bank of America Corp DE Reduces Position in CONMED Co. (NASDAQ:CNMD)
08:56am, Wednesday, 01'st Apr 2020
Bank of America Corp DE lessened its holdings in shares of CONMED Co. (NASDAQ:CNMD) by 6.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC
Global Cartilage Repair and Regeneration Market, by Treatment Modalities, Procedure Type and Application to 2022
08:03am, Wednesday, 01'st Apr 2020
Dublin, April 01, 2020 -- The "Global Cartilage Repair and Regeneration Market, by Treatment Modalities (Cell-Based Approach, Non-Cell-Based Approach), by Procedure Type,.
CONMED Co. (NASDAQ:CNMD) Receives Average Rating of "Hold" from Brokerages
07:30am, Wednesday, 01'st Apr 2020
Shares of CONMED Co. (NASDAQ:CNMD) have been given a consensus rating of “Hold” by the nine ratings firms that are presently covering the firm, Marketbeat.com reports. One research analyst has rat
New York, March 31, 2020 -- Reportlinker.com announces the release of the report "Global Biliary Stent Market - Premium Insight, Competitive News Feed Analysis, Company.
CONMED Corporation Announces Virtual 2020 Annual Meeting of Shareholders
08:05pm, Tuesday, 31'st Mar 2020
CONMED Corporation (NYSE: CNMD) today announced that the 2020 Annual Meeting of Shareholders will be held on May 21, 2020 at 1:30 p.m. ET. Shareholders as of the close of business on the record date,
New York, March 31, 2020 -- Reportlinker.com announces the release of the report "Global Trocar Market - Premium Insight, Competitive News Feed Analysis, Company Usability.
